CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Guggenheim Adjusts Price Target on Elevance Health to $460 From $455

Neutral
AI Analysis

Summary

Guggenheim adjusted its price target on Elevance Health to $460 from $455, a minor upward revision.

Importance:2/10
Sentiment:
0.15
price_targetanalyst_rating
Related Companies

Read the original article

Published by yahoo_finance on October 12, 2026 12:44 PM

Read Original